Tethering of PMNL by platelets via CD62P has been shown to cause PMNL activ
ation. Go-incubation of purified PMNL with platelets that were activated wi
th thrombin and then fixed and washed, resulted in the formation of platele
t-PMNL conjugates as well as in a generation of reactive oxygen species tha
t were measured as luminol-enhanced chemiluminescence. When platelets were
thrombin activated in the presence of RGDS to prevent binding of fibrinogen
to membrane receptors, they had a reduced capacity to adhere to PMNL, but
ROS generation was enhanced. In samples of citrated whole blood RGDS as wel
l as the more specific platelet fibrinogen receptor antagonist GR144053F or
a dissociation of the platelet glycoprotein IIb/IIIa complex markedly enha
nced ROS generation that was induced by stirring the samples for 10 min at
1000 rpm, by 175%, 95% and 138%, respectively. Removal of platelets from th
e whole blood samples also resulted in an enhancement of stirring-induced R
OS generation, which was inversely correlated to the platelet count. These
data provide some evidence that platelets are capable of inhibiting ROS gen
eration in PMNL by a mechanism that involves platelet-bound fibrinogen and
probably depends on fibrinogen-mediated platelet-PMNL contact.